b-cryptoxanthin
Small moleculeexperimental
Clinical trial activity
5 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2010 (NCT01074723)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- b-cryptoxanthin
- b-cryptoxanthin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05046457 | N/A | Sep 7, 2021 | DSM, Singapore Institute for Clinical Sciences |
| NCT04153968 | N/A | Apr 1, 2019 | International Food Policy Research Institute, Newcastle University, Pennsylvania State University |
| NCT03469518 | N/A | Jan 31, 2017 | Autonomous University of Madrid, Hero MotoCorp, Universidad Autonoma de Madrid, University of Valencia |
| NCT02065024 | Phase 1 | Mar 1, 2014 | Autonomous University of Madrid |
| NCT01074723 | Phase 1 | Feb 1, 2010 | Autonomous University of Madrid |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Autonomous University of Madrid | Academic/Hospital | 3 | 3 | 2 | 2010 |
| DSM | For profit | 1 | 0 | 1 | 2021 |
| Hero MotoCorp | For profit | 1 | 0 | 1 | 2017 |
| International Food Policy Research Institute | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Newcastle University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Pennsylvania State University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Singapore Institute for Clinical Sciences | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Universidad Autonoma de Madrid | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of Valencia | Academic/Hospital | 1 | 0 | 1 | 2017 |
9 organizations
Page 1 / 1